(Q35091194)

6 August 2017

1 reference

title

Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens (English)

1 reference

6 August 2017

1 reference

cervix uterine cancer

1 reference

Frank C S Wong

1

1 reference

6 August 2017

Stewart Y Tung

2

1 reference

6 August 2017

To-Wai Leung

3

1 reference

6 August 2017

Wing-Kin Sze

4

1 reference

6 August 2017

Victy Y W Wong

5

1 reference

6 August 2017

Collin M M Lui

6

1 reference

6 August 2017

Kwok-Keung Yuen

7

1 reference

6 August 2017

Sai-Ki O

8

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

International Journal of Radiation Oncology Biology Physics

6 August 2017

published in

1 reference

6 August 2017

volume

55

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

page(s)

1254-1264

1 reference

Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High dose rate afterloading intracavitary therapy in carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with a low-dose rate system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate afterloading technique in the radiation treatment of uterine cervical cancer: 399 cases and 9 years experience in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Dose-tumor response of carcinoma of cervix: an analysis of 594 patients treated by radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Chemoradiation and adjuvant chemotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Chemoradiation for locally advanced cervical cancer: does it help?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Chemoradiation: the new gold standard for non-surgical treatment of cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong: unexpectedly high complication rate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Youth as a prognostic factor in carcinoma of the cervix: a matched analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

Prediction of severe late complications in fractionated, high dose-rate brachytherapy in gynecological applications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904525-X

7 January 2021

10.1016/S0360-3016(02)04525-X

Identifiers

DOI

1 reference

release_psgx4giltvampjevlgv7yfhcqu

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/psgx4giltvampjevlgv7yfhcqu

24 November 2022

mapped directly with Wikidata item

1 reference